coronavirus

Inhibiting a protein involved in programmed cell death leads to reduced coronavirus replication

by Edward Chen Historical evidence shows that developing safe vaccines is necessary to protect the world from deadly diseases. But that’s only one part of the solution. After all, what’s the benefit of having vaccines that people don’t want to use?…

by Edward Chen The COVID-19 pandemic has catalyzed rapid technological advancements as scientists and engineers mobilize to combat its toll on human lives. Time is of the essence, and after rigorous testing for safety and effectiveness, there are now…

Breakthrough research published in Nucleic Acids Research suggests SARS-CoV-2-related RNA may serve as potential drug targets for COVID-19.

by Sam Berry In 1918, a new influenza (flu) strain infected nearly a third of the world’s population, leaving tens of millions dead. At the time, relatively little was known about this strain, later called the Spanish Flu—why it was so dangerous, how…

Catherine (Xiaoxiao) Ding is a second-year Applied Math Ph.D. student in the School of Engineering and Applied Sciences at Harvard University, where she is studying  programmable materials. Daniel Utter is a 5th year Ph.D. student in Organismic and…

by Apurva Govande figures by Tal Scully COVID-19, the disease caused by the newly discovered virus SARS-CoV-2, is a national emergency. We need a vaccine to prevent severe outcomes of disease, to successfully combat future outbreaks of this virus,…

by Kayla Davisfigures by Jovana Andrejevic With COVID-19 cases showing up across much of the United States, many people are increasingly curious if they have contracted the disease. Although the COVID-19 infection rate continues to rise, tests are…

The global pandemic lockdown has contributed to declines in carbon emission and is shifting the way scientists and economists discuss climate change mitigation tactics, but it’s still not enough to prevent projected temperature increases past 1.5°C.